Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ammonium formate | HCID 2723923 | — |
| Reactant | HCID 136055985 | HCID 136055985 | — |
| Catalyst | Palladium | HCID 23938 | — |
| Solvent | Ethanol | HCID 702 | — |
| Product | HCID 136055975 | HCID 136055975 | 66.4% |
Reaction Steps
A suspension of 360 mg of 5-benzyloxy-3-[5-(2-piperidin-1-ylethoxy)-1H-indol-2-yl]-1H-indazole, 916 mg of ammonium formate and 120 mg of palladium in 10 ml of ethanol is placed in a reactor that is irradiated in a microwave field (Synthwave 402) at a temperature of 90° C. for 30 minutes and the reaction mixture is then filtered through a bed of celite. The filtrate is evaporated under reduced pressure and the residue is then-taken up in a mixture of ethyl acetate (150 ml) and of water (50 ml). A 30% ammonium hydroxide solution is added so as to bring the pH to 10. After separation by settling out and extraction with ethyl acetate (1×50 ml), the organic extracts are combined, dried over magnesium sulfate and then evaporated under reduced pressure. 193 mg of 3-[5-(2-piperidin-1-ylethoxy)-1H-indol-2-yl]-1H-indazol-5-ol are isolated and characterized.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07491710B2 |
|---|
| Source dataset | uspto-grants-2009_02 |
|---|
| ORD ID | ord-b623fd9c923749019dd9458d7110a6ab |
|---|
| Source note | uspto-grants-2009_02 |
|---|